NPPB and coronary artery disorder: In this study, we aimed to determine whether plasma levels of NT-proBNP and other biomarkers altered with changes in the severity of CHD, and whether these markers are appropriate for rapidly identifying symptomatic or asymptomatic CHD in diabetic or pre-diabetic Chinese patients.